Search research articles
Contact Us
Filters
Showing results (321-330 of 415) with videos related to
Page
of 42
Sort By:
JAMA Oncology
|
February 14, 2020
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial
Fausto Petrelli, Roberto Labianca, Alberto Zaniboni, et al.
The Oncologist
|
January 17, 2020
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis
Gerardo Rosati, Fabio Galli, Maurizio Cantore, et al.
Journal of Cellular Physiology
|
May 18, 2016
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial
Laura Pizzuti, Maddalena Barba, Diana Giannarelli, et al.
Journal of Translational Medicine
|
May 3, 2015
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
Carmela Rozera, Giancarlo Antonini Cappellini, Giuseppina D'Agostino, et al.
Pharmacogenomics
|
October 8, 2019
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation
Csilla Sipeky, Adrián Llerena, Vangelis G Manolopoulos, et al.
Cancer Investigation
|
February 4, 2014
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program
Paolo Antonio Ascierto, Ester Simeone, Vanna Chiarion Sileni, et al.
International Journal of Colorectal Disease
|
May 9, 2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference
Michela Roberto, Paolo Marchetti, Giulia Arrivi, et al.
Journal of Personalized Medicine
|
December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
Armando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Anticancer Research
|
August 2, 2019
Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases
Diego Cortinovis, Rita Chiari, Annamaria Catino, et al.
European Journal of Cancer Care
|
October 2, 2019
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network
Mariavita Ciccarone, Stefan Hohaus, Alessandro Pulsoni, et al.
Page
of 42
Search research articles
Search
Showing results (321-330 of 415) with videos related to
Sort By:
Page
of 42
JAMA Oncology
|
February 14, 2020
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial
Fausto Petrelli, Roberto Labianca, Alberto Zaniboni, et al.
The Oncologist
|
January 17, 2020
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis
Gerardo Rosati, Fabio Galli, Maurizio Cantore, et al.
Journal of Cellular Physiology
|
May 18, 2016
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial
Laura Pizzuti, Maddalena Barba, Diana Giannarelli, et al.
Journal of Translational Medicine
|
May 3, 2015
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
Carmela Rozera, Giancarlo Antonini Cappellini, Giuseppina D'Agostino, et al.
Pharmacogenomics
|
October 8, 2019
4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation
Csilla Sipeky, Adrián Llerena, Vangelis G Manolopoulos, et al.
Cancer Investigation
|
February 4, 2014
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program
Paolo Antonio Ascierto, Ester Simeone, Vanna Chiarion Sileni, et al.
International Journal of Colorectal Disease
|
May 9, 2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference
Michela Roberto, Paolo Marchetti, Giulia Arrivi, et al.
Journal of Personalized Medicine
|
December 23, 2020
Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2- Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
Armando Orlandi, Elena Iattoni, Laura Pizzuti, et al.
Anticancer Research
|
August 2, 2019
Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases
Diego Cortinovis, Rita Chiari, Annamaria Catino, et al.
European Journal of Cancer Care
|
October 2, 2019
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network
Mariavita Ciccarone, Stefan Hohaus, Alessandro Pulsoni, et al.
Page
of 42